- Seidlerová J, Filipovský J, Mayer O, Wohlfahrt P, Cífková R. Positive effects of antihypertensive treatment on aortic stiffness in the general population. Hypertens Res. 2014; 37, 64–68.
- Wohlfahrt P, Krajčoviechová A, Seidlerová J, Mayer O, Bruthans J, Filipovský J, Laurent S, Cífková R. Arterial stiffness parameters: How do they differ? Atherosclerosis 2013; 231: 359-364.
- Mayer O, Seidlerová J, Bruthans J, Filipovský J, Timoracká K, Vaněk J, Černá L, Wohlfahrt P, Cífková R, Theuwissen E, Vermeer C. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 2014; 235: 162-168.
- Hirmerová J, Seidlerová J, Šubrt I. Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs. Cross-sectional single center study of prevalence and risk factors. International Angiology 2013;32: 410-416.
- Seidlerová J, Filipovský J, Mayer O Jr, Kučerová A, Pešta M. Association between endothelial NO synthase polymorphisms and arterial properties in the general population. Nitric Oxide 2015; 44: 47–51.
- Mayer O Jr, Filipovský J, Pešta M, Cífková R, Dolejšová M, Šimon J. Synergistic effect of angiotensin II type 1 receptor and endothelial nitric oxide synthase gene polymorphisms on arterial stiffness. J Hum Hypertens. 2008; 22: 111-118.
- De Bacquer D, Dallongeville J, Kotseva K, Cooney MT, Pajak A, Deckers JW, Mayer O, Vanuzzo D, Lehto S, Fras Z, Östor E, Ambrosio GB, De Backer G, Wood D, Keil U, Sans S, Graham I, Pyörälä K. Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE Risk Categories. Int J Cardiol. 2013; 168: 910-914.